Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease

Clinical trial NCT00252850 · COMPLETED

Trial details

NCT number: NCT00252850
Sponsor: Sangamo Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2005-06-01
Primary completion: 2007-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.